TWD
ANIK icon

True Wealth Design’s Anika Therapeutics ANIK Stock Holding History

True Wealth Design’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.08K Buy
142
+32
+29% +$474 ﹤0.01% 1676
2026
Q1 		$1.59K Buy
110
+40
+57% +$464 ﹤0.01% 1627
2025
Q4 		$673 Buy
70
+19
+37% +$182 ﹤0.01% 1851
2025
Q3 		$480 Buy
51
+42
+467% +$401 ﹤0.01% 2017
2025
Q2 		$96 Buy
+9
New +$114 ﹤0.01% 2247
2025
Q1 		– Sell
-29
Closed -$478 – 2652
2024
Q4 		$478 Buy
+29
New +$572 ﹤0.01% 1102

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return

True Wealth Design's ANIK Position: Q2 2026 in Review

True Wealth Design increased its Anika Therapeutics (ANIK) stake by 29% in Q2 2026, buying an estimated $474 and bringing the position to 142 shares worth $2.08K. The position accounts for ﹤0.01% of the portfolio, ranked #1676.

True Wealth Design first reported a position in ANIK in Q4 2024 and has held it in 6 quarters since. 133 funds tracked by Wall St. Rank hold ANIK as of Q2 2026.

  • True Wealth Design held 142 shares of Anika Therapeutics worth $2.08K as of Q2 2026.
  • True Wealth Design bought 32 Anika Therapeutics shares in Q2 2026, an estimated $474.
  • Anika Therapeutics made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #1676 holding.
  • True Wealth Design first reported a position in Anika Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • 133 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.